Clinical Guidelines

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

Share

Researchers in Germany have identified an epigenetic marker for prediabetes detectable through a single blood draw, which could transform diabetes risk assessment. This new method leverages DNA methylation profiling to distinguish between individuals at high and low risk, eliminating the need for extensive clinical tests. Early identification may prevent or delay Type 2 diabetes onset, addressing both clinical and economic burdens. The approach's prognostic potential is bolstered by its ability to predict metabolic decline and future complications, advancing towards noninvasive testing options.

Original Source(s)

Diabetes Risk Assessment: A New Approach

Blood-based epigenetic markers show strong prognostic potential for Type 2 diabetes

  • by Helen Bristow

  • March 9, 2026

  • 5 min

Related Content

AI Model Finds Hidden Risk Signals in CGM Data

GluFormer accurately identified patients likely to experience clinically meaningful rises in HbA1c over a 2-year period.

AI's Expanding Role in Diabetes Care

Machine learning models applied to inpatient electronic health record data have predicted insulin needs more accurately than traditional guidelines.

Stratifying Prediabetes by DNA

Blood-based methylation profiles reproduced high-risk clusters without complex metabolic testing.